GLP-1 Peptides Explained: Semaglutide, Tirzepatide, and Retatrutide; Appetite Control in Medical Weight Loss

If you’ve been following conversations around medical weight loss, you’ve probably heard about GLP-1 medications. These treatments have been some of the most talked-about metabolic therapies in recent years.

In the Peptides Made Simple (PMS) series, number five focuses on a group of compounds often used together in discussion: GLP-1 receptor agonists such as semaglutide, tirzepatide, and other appetite-regulating peptides.

Despite the headlines and occasional stigma surrounding them, these therapies are still widely used in functional medicine clinics, metabolic health practices, and weight management programs when prescribed and monitored appropriately.

What Are GLP-1 Peptides?

GLP-1 (Glucagon-Like Peptide-1) is a hormone naturally produced in the gut that plays an important role in blood sugar regulation, appetite control, and metabolism.

GLP-1 medications and peptides are designed to mimic or enhance the activity of this hormone. This can help regulate several metabolic processes, including:

• Appetite and satiety signals

• Blood sugar levels

• Insulin sensitivity

• Gastric emptying (how quickly food leaves the stomach)

Because of these effects, GLP-1 therapies are commonly used in medical weight loss and metabolic health programs.

Common GLP-1 Medications

Several GLP-1 receptor agonists have gained significant attention in recent years, including:

• Semaglutide

• Tirzepatide

• Other GLP-based metabolic peptides used in clinical settings

These therapies are part of a broader category known as incretin-based treatments, which help regulate the body’s metabolic signaling.

How GLP-1 Therapies Support Weight Loss

GLP-1 receptor agonists influence metabolism in several key ways.

• Appetite Regulation
• One of the most well-known effects is reduced hunger and improved satiety. People often feel full sooner and eat smaller portions.
• Improved Insulin Sensitivity
• GLP-1 signaling helps the body respond more effectively to insulin, which can be especially helpful for individuals experiencing insulin resistance.
• Slower Gastric Emptying
• Food moves through the digestive system more slowly, which helps stabilize blood sugar and extend feelings of fullness.
• Hormonal Balance Support
• For some individuals with metabolic or hormonal imbalances, improving insulin signaling may make weight loss possible after other strategies haven’t worked.
• Why Some People Experience Side Effects

While GLP-1 therapies can be effective, dosage and medical supervision matter.

One of the most common reasons people experience side effects is starting at a dose that is too high. When dosing is increased too quickly, some individuals may experience symptoms such as:

• Headaches
• Nausea
• Constipation
• Digestive discomfort

In some cases, these symptoms can also occur because food intake decreases significantly, which may lead people to unintentionally:

• drink less water
• consume fewer nutrients
• eat too little protein

This is why many providers emphasize gradual dose adjustments, hydration, and proper nutrition when using GLP-1 therapies.

Why GLP-1 Therapies Are Still Used in Medical Clinics

Although public conversations around GLP-1 medications have fluctuated, these treatments remain a valuable tool in metabolic medicine when used appropriately.

They are often considered for individuals who:

• Have insulin resistance
• Struggle with hormonal weight gain
• Have tried diet and exercise without success
• Experience metabolic slowdown despite lifestyle changes

For people who feel like they’ve “done everything” — improving diet, increasing movement, and optimizing sleep — GLP-1 therapies may provide an additional metabolic pathway to support weight regulation.Why Medical Supervision Matters

GLP-1 therapies should always be prescribed and monitored by a qualified healthcare provider.

Safe use typically involves:

• individualized dosing
• gradual titration
• monitoring metabolic markers
• nutritional guidance
• hydration and lifestyle support

When used in a structured medical program, these therapies are designed to support long-term metabolic health rather than rapid short-term weight loss.

The Bottom Line

GLP-1 receptor agonists such as semaglutide and tirzepatide have transformed the conversation around medical weight management and insulin resistance.

Rather than simply suppressing appetite, they work through metabolic signaling pathways that influence blood sugar regulation, hunger hormones, and energy balance.

For individuals struggling with stubborn weight gain despite healthy habits, GLP-1 therapies can sometimes provide the metabolic support needed to restore balance—especially when used carefully under professional guidance.

In the evolving field of peptide therapy and metabolic medicine, GLP-1 treatments continue to play an important role in helping patients address insulin resistance, hormone imbalance, and sustainable weight loss.

-Dr. Katharine Schneller, NMD of Inclusive Natural Medicine

If you are ready to start your peptide journey with Inclusive Natural Medicine, please contact our office at 480-712-7499 or click here to schedule your first appointment.

All information is for educational purposes only and is not intended to treat cure or diagnose any illness. For medical care please contact our office for an appointment.